<DOC>
	<DOCNO>NCT01384565</DOCNO>
	<brief_summary>Study Design 50 patient enrolled randomized patient ( Group IA ) control ( Group I B ) Investigations : Hematology CBC , Prothrombin time INR Peripheral smear , Retics Biochemistry Liver function testing , AFP Kidney function test Etiology chronic liver disease Infectious etiology : total antiHBc , anti HCV , HCV RNA , HBV DNA Non infectious etiology : Autoimmune marker , copper study , iron study , HOMA IR , FBS Etiology decompensation Variceal bleed Infection ( blood culture , urine culture , sputum culture , chest xray ) Surgery Drugs Alcohol intake Ascitic fluid analysis UGI endoscopy Imaging USG abdomen Doppler spleno-portal axis CECT- Triple phase upper abdomen Liver regenerative potential efficacy test Histology ( transjugular liver biopsy ) Liver Dendritic cell ( CD11c , CD40 , CD 54 , CD 123 , BDCA 2 staining ) flow cytometry CD 34+ cell , CD 45+ cell CD 133+ cell measurement hepatic venous blood , peripheral blood liver biopsy flow cytometry Markers proliferation like Ki- 67 , proliferate cell nuclear antigen ( PCNA ) liver biopsy Markers angiogenesis like VEGF , v WF hepatic venous blood Measurement Hepatic venous pressure gradient ( HVPG )</brief_summary>
	<brief_title>G-CSF Erythropoetin Survival Patients With Decompensated Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>All patient know cirrhosis liver portal hypertension , decompensated ascites/ jaundice/ bleed/ HE/ HRS Age &lt; 12 &gt; 75 year Autoimmune disorder HCC Sepsis ( Any culture positive : blood , urine , obvious source infection : UTI , SBP ) Multi organ failure Grade 4 HE HIV seropositivity / pregnancy Essential Hypertension Patients take transplant Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>